Hiroyuki Takamatsu

17PUBLICATIONS
47CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Molecular targetsMedical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 07, 2025
Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review.

Heinz Ludwig, Sarah Bernhard, Takashi Ikeda

|Aug 19, 2024
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT).

Laurent Garderet, Luuk Gras, Linda Koster

|Mar 01, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

Yasunori Kogure, Hiroshi Handa, Yuta Ito

|Feb 23, 2023
Eight-color multiparameter flow cytometry (EuroFlow-NGF) is as sensitive as next-generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma.

Ryota Urushihara, Naoki Takezako, Takeshi Yoroidaka

|Nov 08, 2022
Antibody status following booster vaccination against SARS-CoV-2 virus in patients with haematologic malignancies.

Daisuke Ikeda, Toshiki Terao, Ami Fukumoto

|Sep 02, 2022
Hematopoietic stem progenitor cells with malignancy-related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4.

Takamasa Katagiri, Jorge Luis Espinoza, Mizuho Uemori

Pageof 3

Frequent Collaborators

2 joint publications

Kosei Matsue

2 joint publications

Hiroshi Handa

2 joint publications

Junya Kuroda

1 joint publications

Toshihiro Miyamoto